Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BIOLOGICAL PHENOTYPE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 183 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Grivel, JC; Ito, Y; Faga, G; Santoro, F; Shaheen, F; Malnati, MS; Fitzgerald, W; Lusso, P; Margolis, L
      Suppression of CCR5-but not CXCR4-tropic HIV-1 in lymphoid tissue by humanherpesvirus 6

      NATURE MEDICINE
    2. Morris, L; Cilliers, T; Bredell, H; Phoswa, M; Martin, DJ
      CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    3. Messele, T; De Wit, TFR; Brouwer, M; Aklilu, M; Birru, T; Fontanet, AL; Schuitemaker, H; Hamann, D
      No difference in in vitro susceptibility to HIV type 1 between high-risk HIV-negative ethiopian commercial sex workers and low-risk control subjects

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    4. Ghezzi, S; Menzo, S; Brambilla, A; Bordignon, PP; Lorini, AL; Clementi, M; Poli, G; Vicenzi, E
      Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands

      VIROLOGY
    5. Tscherning-Casper, C; Vodros, D; Menu, E; Aperia, K; Fredriksson, R; Dolcini, G; Chaouat, G; Barre-Sinoussi, F; Albert, J; Fenyo, EM
      Coreceptor usage of HIV-1 isolates representing different genetic subtypesobtained from pregnant Cameroonian women

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Medina, D
      The preneoplastic phenotype in murine mammary tumorigenesis

      JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
    7. Nokta, M; Turk, P; Loesch, K; Pollard, RB
      Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: Relationship to HIV viral load and CD4 cell count

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    8. Wang, WK; Lee, CN; Dudek, T; Chang, SY; Zhao, YJ; Essex, M; Lee, TH
      Interaction between HIV type 1 glycoprotein 120 and CXCR4 coreceptor involves a highly conserved arginine residue in hypervariable region 3

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    9. Wooley, DP; Peterson, KT; Taylor, RJ; Paul, CC; Baumann, MA
      Strain-dependent productive infection of a unique eosinophilic cell line by human immunodeficiency virus type 1

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    10. Clerici, M; Butto, S; Lukwiya, M; Saresella, M; Declich, S; Trabattoni, D; Pastori, C; Piconi, S; Fracasso, C; Fabiani, M; Ferrante, P; Rizzardini, G; Lopalco, L
      Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5

      AIDS
    11. Lallos, LB; Cecilia, D; Fenyo, EM; Laal, S; Zolla-Pazner, S
      HIV phenotype correlates with the relative amounts of lymphocyte function-related molecule 1 (LFA-1) and major histocompatibility complex (MHC) classII in the virion envelope

      AIDS
    12. Candotti, D; Adu-Sarkodie, Y; Davies, F; Baldrich-Rubio, E; Stirrups, K; Lee, H; Allain, JP
      AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection

      JOURNAL OF MEDICAL VIROLOGY
    13. Wunschmann, S; Stapleton, JT
      Fluorescence-based quantitative methods for detecting human immunodeficiency virus type 1-induced syncytia

      JOURNAL OF CLINICAL MICROBIOLOGY
    14. Blaak, H; Ran, LJ; Rientsma, R; Schuitemaker, H
      Susceptibility of in vitro stimulated PBMC to infection with NSIHIV-1 is associated with levels of CCR5 expression and beta-chemokine production

      VIROLOGY
    15. Blaak, H; van't Wout, AB; Brouwer, M; Hooibrink, B; Hovenkamp, E; Schuitemaker, H
      In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    16. Hu, QX; Barry, AP; Wang, ZX; Connolly, SM; Peiper, SC; Greenberg, ML
      Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis

      JOURNAL OF VIROLOGY
    17. Torre, VS; Marozsan, AJ; Albright, JL; Collins, KR; Hartley, O; Offord, RE; Quinones-Mateu, ME; Arts, EJ
      Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs

      JOURNAL OF VIROLOGY
    18. Equils, O; Garratty, E; Wei, LS; Plaeger, S; Tapia, M; Deville, J; Krogstad, P; Sim, MS; Nielsen, K; Bryson, YJ
      Recovery of replication-competent virus from CD4 T cell reservoirs and change in coreceptor use in human immunodeficiency virus type 1-infected children responding to highly active antiretroviral therapy

      JOURNAL OF INFECTIOUS DISEASES
    19. van Rij, RP; Blaak, H; Visser, JA; Brouwer, M; Rientsma, R; Broersen, S; Husman, AMD; Schuitemaker, H
      Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1

      JOURNAL OF CLINICAL INVESTIGATION
    20. Peeters, M; Vincent, R; Perret, JL; Lasky, M; Patrel, D; Liegeois, F; Courgnaud, V; Seng, R; Matton, T; Molinier, S; Delaporte, E
      Evidence for differences in MT2 cell tropism according to genetic subtypesof HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    21. Favia, A; Di Stefano, M; Fiore, JR; Pastore, G; Angarano, G
      Phenotypic patterns of HIV-1 clonal populations during highly active antiretroviral therapy (HAART)

      MICROBIOLOGICA
    22. Rha, SY; Noh, SH; Kim, TS; Yoo, NC; Roh, JK; Min, JS; Kim, BS; Kim, MY; Chung, HC
      Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    23. Jansson, M; Backstrom, E; Bjorndal, A; Holmberg, V; Rossi, P; Fenyo, EM; Popovic, M; Albert, J; Wigzell, H
      Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS

      JOURNAL OF HUMAN VIROLOGY
    24. Verrier, F; Borman, AM; Brand, D; Girard, M
      Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    25. Abebe, A; Demissie, D; Goudsmit, J; Brouwer, M; Kuiken, CL; Pollakis, G; Schuitemaker, H; Fontanet, AL; de Wit, TFR
      HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS

      AIDS
    26. Candotti, D; Costagliola, D; Joberty, C; Bonduelle, O; Rouzioux, C; Autran, B; Agut, H
      Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism

      JOURNAL OF MEDICAL VIROLOGY
    27. Sabri, F; Tresoldi, E; Di Stefano, M; Polo, S; Monaco, MC; Verani, A; Fiore, JR; Lusso, P; Major, E; Chiodi, F; Scarlatti, G
      Nonproductive human immunodeficiency virus type 1 infection of human fetalastrocytes: Independence from CD4 and major chemokine receptors

      VIROLOGY
    28. Sato, H; Kato, K; Takebe, Y
      Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop

      VIROLOGY
    29. Penn, ML; Grivel, JC; Schramm, B; Goldsmith, MA; Margolis, L
      CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    30. Baba, M; Nishimura, O; Kanzaki, N; Okamoto, M; Sawada, H; Iizawa, Y; Shiraishi, M; Aramaki, Y; Okonogi, K; Ogawa, Y; Meguro, K; Fujino, M
      A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    31. Resino, S; Jimenez, JL; Gurbindo, D; Munoz-Fernandez, MA
      Prognostic markers of survival in infants younger than 12 months vertically infected by human immunodeficiency virus type-1

      MEDICINA CLINICA
    32. Yi, YJ; Isaacs, SN; Williams, DA; Frank, I; Schols, D; De Clercq, E; Kolson, DL; Collman, RG
      Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: Two distinct mechanisms of HIV-1 dual tropism

      JOURNAL OF VIROLOGY
    33. Berkowitz, RD; van't Wout, AB; Kootstra, NA; Moreno, ME; Linquist-Stepps, VD; Bare, C; Stoddart, CA; Schuitemaker, H; McCune, JM
      R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus

      JOURNAL OF VIROLOGY
    34. Singh, A; Besson, G; Mobasher, A; Collman, RG
      Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood

      JOURNAL OF VIROLOGY
    35. Worgall, S; Connor, R; Kaner, RJ; Fenamore, E; Sheridan, K; Singh, R; Crystal, RG
      Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages

      JOURNAL OF VIROLOGY
    36. Richardson, J; Pancino, G; Merat, R; Leste-Lasserre, T; Moraillon, A; Schneider-Mergener, J; Alizon, M; Sonigo, P; Heveker, N
      Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus

      JOURNAL OF VIROLOGY
    37. Brelot, A; Heveker, N; Adema, K; Hosie, MJ; Willett, B; Alizon, M
      Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses

      JOURNAL OF VIROLOGY
    38. Morner, A; Bjorndal, A; Albert, J; Kewalramani, VN; Littman, DR; Inoue, R; Thorstensson, R; Fenyo, EM; Bjorling, E
      Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage

      JOURNAL OF VIROLOGY
    39. Greco, G; Fujimura, SH; Mourich, DV; Levy, JA
      Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation

      JOURNAL OF VIROLOGY
    40. Kimata, JT; Gosink, JJ; Kewalramani, VN; Rudensey, LM; Littman, DR; Overbaugh, J
      Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne

      JOURNAL OF VIROLOGY
    41. Shankarappa, R; Margolick, JB; Gange, SJ; Rodrigo, AG; Upchurch, D; Farzadegan, H; Gupta, P; Rinaldo, CR; Learn, GH; He, X; Huang, XL; Mullins, JI
      Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection

      JOURNAL OF VIROLOGY
    42. Husman, AMD; van Rij, RP; Blaak, H; Broersen, S; Schuitemaker, H
      Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression

      JOURNAL OF INFECTIOUS DISEASES
    43. Giorgi, JV; Hultin, LE; McKeating, JA; Johnson, TD; Owens, B; Jacobson, LP; Shih, R; Lewis, J; Wiley, DJ; Phair, JP; Wolinsky, SM; Detels, R
      Shorter survival in advanced human immunodeficiency virus type 1 infectionis more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage

      JOURNAL OF INFECTIOUS DISEASES
    44. Husman, AD; Blaak, H; Brouwer, M; Schuitemaker, H
      CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection

      JOURNAL OF IMMUNOLOGY
    45. Abebe, A; Demissie, D; Goudsmit, J; Brouwer, M; Kuiken, CL; Pollakis, G; Schuitemaker, H; Fontanet, AL; de Wit, TFR
      HIV-1 subtype C syncytium- and non-syncytium-Ethiopian patients with AIDS

      ETHIOPIAN MEDICAL JOURNAL
    46. Domingo, E
      Toward an understanding of viruses as complex and dynamic systems

      ANNALES DE MEDECINE VETERINAIRE
    47. KIM A; PETTOELLOMANTOVANI M; GOLDSTEIN H
      DECREASED SUSCEPTIBILITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM INDIVIDUALS HETEROZYGOUS FOR A MUTANT CCR5 ALLELE TO HIV-INFECTION

      Journal of acquired immune deficiency syndromes and human retrovirology
    48. VALLEJO A; HEREDIA A; MAS A; LEE SF; EPSTEIN JS; SORIANO V; HEWLETT IK
      TROPISM, CORECEPTOR USE, AND PHYLOGENETIC ANALYSIS OF BOTH THE V3 LOOP AND THE PROTEASE GENE OF 3 NOVEL HIV-1 GROUP-O ISOLATES

      Journal of acquired immune deficiency syndromes and human retrovirology
    49. PAXTON WA; KANG S
      CHEMOKINE RECEPTOR ALLELIC POLYMORPHISMS - RELATIONSHIPS TO HIV RESISTANCE AND DISEASE PROGRESSION

      Seminars in immunology
    50. WODARZ D; NOWAK MA
      THE EFFECT OF DIFFERENT IMMUNE-RESPONSES ON THE EVOLUTION OF VIRULENTCXCR4-TROPIC HIV

      Proceedings - Royal Society. Biological Sciences
    51. MEDRANO FJ; LEAL M; ARIENTI D; REY C; ZAGLIANI A; TORRES Y; SANCHEZQUIJANO A; LISSEN E; CLERICI M
      TUMOR-NECROSIS-FACTOR-BETA AND SOLUBLE APO-1 FAS INDEPENDENTLY PREDICT PROGRESSION TO AIDS IN HIV-SEROPOSITIVE PATIENTS/

      AIDS research and human retroviruses
    52. Challita-Eid, PM; Klimatcheva, E; Day, BT; Evans, T; Dreyer, K; Rimel, BJ; Rosenblatt, JD; Planelles, V
      Inhibition of HIV type 1 infection with a RANTES-IgG(3) fusion protein

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    53. DISTEFANO M; MONNO L; FIORE JR; BUCCOLIERO G; APPICE A; PERULLI LM; PASTORE G; ANGARANO G
      NEUROLOGICAL DISORDERS DURING HIV-1 INFECTION CORRELATE WITH VIRAL LOAD IN CEREBROSPINAL-FLUID BUT NOT WITH VIRUS PHENOTYPE

      AIDS
    54. BRATT G; KARLSSON A; LEANDERSSON AC; ALBERT J; WAHREN B; SANDSTROM E
      TREATMENT HISTORY AND BASE-LINE VIRAL LOAD, BUT NOT VIRAL TROPISM OR CCR-5 GENOTYPE, INFLUENCE PROLONGED ANTIVIRAL EFFICACY OF HIGHLY-ACTIVE ANTIRETROVIRAL TREATMENT

      AIDS
    55. WOUT ABVT; RAN LJ; NIJHUIS M; TIJNAGEL JMGH; DEGROOT T; VANLEEUWEN R; BOUCHER CAB; SCHUITEMAKER H; SCHUURMAN R
      EFFICIENT INHIBITION OF BOTH SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING WILD-TYPE HIV-1 BY LAMIVUDINE IN-VIVO

      AIDS
    56. TSCHERNING C; ALAEUS A; FREDRIKSSON R; BJORNDAL A; DENG HK; LITTMAN DR; FENYO EM; ALBERT J
      DIFFERENCES IN CHEMOKINE CORECEPTOR USAGE BETWEEN GENETIC SUBTYPES OFHIV-1

      Virology
    57. KINTER A; CATANZARO A; MONACO J; RUIZ M; JUSTEMENT J; MOIR S; ARTHOS J; OLIVA A; EHLER L; MIZELL S; JACKSON R; OSTROWSKI M; HOXIE J; OFFORD R; FAUCI AS
      CC-CHEMOKINES ENHANCE THE REPLICATION OF T-TROPIC STRAINS OF HIV-1 INCD4(-CELLS - ROLE OF SIGNAL-TRANSDUCTION() T)

      Proceedings of the National Academy of Sciences of the United Statesof America
    58. ALVAREZ LP; VERDEJO J; LAHOZ JG; GURBINDO D; HERNANDEZSAMPELAYO T; MORENO E; AZANEDO M; CONTRERAS G; MEDRANO L; NAJERA R
      EXPRESSION OF DIFFERENT HIV-1 PHENOTYPIC SUBPOPULATIONS THROUGH THE NATURAL-HISTORY OF THE INFECTION

      Medicina Clinica
    59. FOLLIS KE; TRAHEY M; LACASSE RA; NUNBERG JH
      CONTINUED UTILIZATION OF CCR5 CORECEPTOR BY A NEWLY DERIVED T-CELL LINE-ADAPTED ISOLATE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Journal of virology
    60. OWEN SM; ELLENBERGER D; RAYFIELD M; WIKTOR S; MICHEL P; GRIECO MH; GAO F; HAHN BH; LAL RB
      GENETICALLY DIVERGENT STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 USE MULTIPLE CORECEPTORS FOR VIRAL ENTRY

      Journal of virology
    61. SPECK RF; PENN ML; WIMMER J; ESSER U; HAGUE BF; KINDT TJ; ATCHISON RE; GOLDSMITH MA
      RABBIT-CELLS EXPRESSING HUMAN CD4 AND HUMAN CCR5 ARE HIGHLY PERMISSIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION

      Journal of virology
    62. TRKOLA A; KETAS T; KEWALRAMANI VN; ENDORF F; BINLEY JM; KATINGER H; ROBINSON J; LITTMAN DR; MOORE JP
      NEUTRALIZATION SENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRIMARY ISOLATES TO ANTIBODIES AND CD4-BASED REAGENTS IS INDEPENDENT OF CORECEPTOR USAGE

      Journal of virology
    63. LEWIS J; BALFE P; ARNOLD C; KAYE S; TEDDER RS; MCKEATING JA
      DEVELOPMENT OF A NEUTRALIZING ANTIBODY-RESPONSE DURING ACUTE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION AND THE EMERGENCE OF ANTIGENIC VARIANTS

      Journal of virology (Print)
    64. ZHANG LQ; HE T; HUANG YX; CHEN ZW; GUO Y; WU S; KUNSTMAN KJ; BROWN RC; PHAIR JP; NEUMANN AU; HO DD; WOLINSKY SM
      CHEMOKINE CORECEPTOR USAGE BY DIVERSE PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Journal of virology (Print)
    65. RADAELLI A; KRAUS G; SCHMIDT A; BADEL P; MCCLURE J; HU SL; MORTON W; MORGHEN CD; WONGSTAAL F; LOONEY D
      GENETIC-VARIATION IN A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 LIVE-VIRUSMACACA-NEMESTRINA VACCINE MODEL

      Journal of virology
    66. REINHART TA; ROGAN MJ; AMEDEE AM; MURPHEYCORB M; RAUSCH DM; EIDEN LE; HAASE AT
      TRACKING MEMBERS OF THE SIMIAN IMMUNODEFICIENCY VIRUS DELTAB670 QUASI-SPECIES POPULATION IN-VIVO AT SINGLE-CELL RESOLUTION

      Journal of virology
    67. BLAAK H; VANTWOUT AB; BROUWER M; CORNELISSEN M; KOOTSTRA NA; ALBRECHTVANLENT N; KEET RPM; GOUDSMIT J; COUTINHO RA; SCHUITEMAKER H
      INFECTIOUS CELLULAR LOAD IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-INFECTED INDIVIDUALS AND SUSCEPTIBILITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM THEIR EXPOSED PARTNERS TO NON-SYNCYTIUM-INDUCING HIV-1AS MAJOR DETERMINANTS FOR HIV-1 TRANSMISSION IN HOMOSEXUAL COUPLES

      Journal of virology
    68. PONTESILLI O; KLEIN MR; KERKHOFGARDE SR; PAKKER NG; DEWOLF F; SCHUITEMAKER H; MIEDEMA F
      LONGITUDINAL ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFICCYTOTOXIC T-LYMPHOCYTE RESPONSES - A PREDOMINANT GAG-SPECIFIC RESPONSE IS ASSOCIATED WITH NONPROGRESSIVE INFECTION

      The Journal of infectious diseases
    69. YU XF; WANG Z; VLAHOV D; MARKHAM RB; FARZADEGAN H; MARGOLICK JB
      INFECTION WITH DUAL-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS ASSOCIATED WITH RAPID TOTAL T-CELL DECLINE AND DISEASE PROGRESSION IN INJECTION-DRUG USERS

      The Journal of infectious diseases
    70. VIANI RM; SMITH IL; SPECTOR SA
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPES IN CHILDREN WITH ADVANCED DISEASE TREATED WITH LONG-TERM ZALCITABINE

      The Journal of infectious diseases
    71. BLAAK H; BROUWER M; RAN LJ; DEWOLF F; SCHUITEMAKER H
      IN-VITRO REPLICATION KINETICS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) VARIANTS IN RELATION TO VIRUS LOAD IN LONG-TERM SURVIVORS OF HIV-1 INFECTION

      The Journal of infectious diseases
    72. Torres, Y; Medrano, FJ; Rey, C; Calderon, EJ; Sanchez-Quijano, A; Lissen, E; Leal, M
      Evidence for a role of T-helper type 2 cytokines in the acquisition of human immunodeficiency virus syncytium-inducing phenotype

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    73. MELLADO MJ; CILLERUELO MJ; ORTIZ M; VILLOTA J; GARCIA M; PEREZJURADO ML; BARREIRO G; MARTINFONTELOS P; BERNAL A
      VIRAL PHENOTYPE, ANTIRETROVIRAL RESISTANCE AND CLINICAL EVOLUTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN

      The Pediatric infectious disease journal
    74. KOOTSTRA NA; MIEDEMA F; SCHUITEMAKER H
      ANALYSIS OF CD8(-LYMPHOCYTE-MEDIATED NONLYTIC SUPPRESSION OF AUTOLOGOUS AND HETEROLOGOUS PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES() T)

      AIDS research and human retroviruses
    75. BARRESINOUSSI F; GEORGESCOURBOT MC; FULTZ PN; TUYET HNT; MUCHMORE E; SARAGOSTI S; DUBREUIL G; GEORGES A; VANDERRYST E; GIRARD M
      CHARACTERIZATION AND TITRATION OF AN HIV TYPE-1 SUBTYPE-E CHIMPANZEE CHALLENGE STOCK

      AIDS research and human retroviruses
    76. GROENINK M; SWART PJ; BROERSEN S; KUIPERS M; MEIJER DKF; SCHUITEMAKER H
      POTENT INHIBITION OF REPLICATION OF PRIMARY HIV TYPE-1 ISOLATES IN PERIPHERAL-BLOOD LYMPHOCYTES BY NEGATIVELY CHARGED HUMAN SERUM ALBUMINS

      AIDS research and human retroviruses
    77. OLIVARES I; SHAW G; LOPEZGALINDEZ C
      PHENOTYPIC SWITCH IN A SPANISH HIV TYPE-1 ISOLATE ON SERIAL PASSAGE ON MT-4 CELLS

      AIDS research and human retroviruses
    78. MUNOZFERNANDEZ MA; NAVARRO J; OBREGON E; ARIAS RA; GURBINDO MD; SAMPELAYO TH; FERNANDEZCRUZ E
      IMMUNOLOGICAL AND VIROLOGICAL MARKERS OF DISEASE PROGRESSION IN HIV-INFECTED CHILDREN

      Acta paediatrica
    79. ENOSE Y; OKADA M; SATA T; MA W; IGARASHI T; IBUKI K; IDO E; HAYAMI M
      RESTRICTION OF VIRAL POPULATION BY INTRAVAGINAL INFECTION OF SIMIAN IMMUNODEFICIENCY VIRUSES IN MACAQUE MONKEYS

      Archives of virology
    80. RHA SY; NOH SH; KWAK HJ; WELLSTEIN A; KIM JH; ROH JK; MIN JS; KIM BS; CHUNG HC
      COMPARISON OF BIOLOGICAL PHENOTYPES ACCORDING TO MIDKINE EXPRESSION IN GASTRIC-CANCER CELLS AND THEIR AUTOCRINE ACTIVITIES COULD BE MODULATED BY PENTOSAN POLYSULFATE

      Cancer letters
    81. FIORE JR; ZHANG YJ; BJORNDAL A; DISTEFANO M; ANGARANO G; PASTORE G; FENYO EM
      BIOLOGICAL CORRELATES OF HIV-1 HETEROSEXUAL TRANSMISSION

      AIDS
    82. ERCOLI L; SARMATI L; NICASTRI E; GIANNINI G; GALLUZZO C; VELLA S; ANDREONI M
      HIV PHENOTYPE SWITCHING DURING ANTIRETROVIRAL THERAPY - EMERGENCE OF SAQUINAVIR-RESISTANT STRAINS WITH LESS CYTOPATHOGENICITY

      AIDS
    83. LIESNARD C; DELFORGE ML; TCHETCHEROFF M; DEMAERTELAER V; FARBER CM; VANVOOREN JP
      IMPORTANCE OF METHOD IN THE DETERMINATION OF SYNCYTIUM-INDUCING PHENOTYPE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLINICAL ISOLATES

      Journal of virological methods
    84. NKENGASONG JN; FRANSEN K; WILLEMS B; KARITA E; VINGERHOETS J; KESTENS L; COLEBUNDERS R; PIOT P; VANDERGROEN G
      VIROLOGICAL, IMMUNOLOGICAL, AND CLINICAL FOLLOW-UP OF A COUPLE INFECTED BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE ONE, GROUP-O

      Journal of medical virology
    85. BRIAND G; BARBEAU B; CORBEIL J; TREMBLAY M
      ENHANCEMENT OF HIV-1-INDUCED SYNCYTIUM FORMATION IN T-CELLS BY THE TYROSYL KINASE P56(LCK)

      Virology
    86. NELSON JAE; FISCUS SA; SWANSTROM R
      EVOLUTIONARY VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 V3 REGION CHARACTERIZED BY USING A HETERODUPLEX TRACKING ASSAY

      Journal of virology
    87. KIMATA JT; OVERBAUGH J
      THE CYTOPATHICITY OF A SIMIAN IMMUNODEFICIENCY VIRUS MNE VARIANT IS DETERMINED BY MUTATIONS IN GAG AND ENV

      Journal of virology
    88. TANAKA Y; KOYANAGI Y; TANAKA R; KUMAZAWA Y; NISHIMURA T; YAMAMOTO N
      PRODUCTIVE AND LYTIC INFECTION OF HUMAN CD4(-1 HELPER T-CELLS WITH MACROPHAGE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1() TYPE)

      Journal of virology
    89. ZHANG YJ; FRACASSO C; FIORE JR; BJORNDAL A; ANGARANO G; GRINGERI A; FENYO EM
      AUGMENTED SERUM NEUTRALIZING ACTIVITY AGAINST PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ISOLATES IN 2 GROUPS OF HIV-1-INFECTED LONG-TERM NONPROGRESSORS

      The Journal of infectious diseases
    90. CONNOR RI; SHERIDAN KE; CERADINI D; CHOE S; LANDAU NR
      CHANGE IN CORECEPTOR USE CORRELATES WITH DISEASE PROGRESSION IN HIV-1-INFECTED INDIVIDUALS

      The Journal of experimental medicine
    91. VANTWOUT AB; RAN LJ; DEJONG MD; BAKKER M; VANLEEUWEN R; NOTERMANS DW; LOELIGER AE; DEWOLF F; DANNER SA; REISS P; BOUCHER CAB; LANGE JMA; SCHUITEMAKER H
      SELECTIVE-INHIBITION OF SYNCYTIUM-INDUCING AND NONSYNCYTIUM-INDUCING HIV-1 VARIANTS IN INDIVIDUALS RECEIVING DIDANOSINE OR ZIDOVUDINE, RESPECTIVELY

      The Journal of clinical investigation
    92. VICENZI E; BAGNARELLI P; SANTAGOSTINO E; GHEZZI S; ALFANO M; SINNONE MS; FABIO G; TURCHETTO L; MORETTI G; LAZZARIN A; MANTOVANI A; MANNUCCI PM; CLEMENTI M; GRINGERI A; POLI G
      HEMOPHILIA AND NONPROGRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION

      Blood
    93. HUSMAN AMD; KOOT M; CORNELISSEN M; KEET IPM; BROUWER M; BROERSEN SM; BAKKER M; ROOS MTL; PRINS M; DEWOLF F; COUTINHO RA; MIEDEMA F; GOUDSMIT J; SCHUITEMAKER H
      ASSOCIATION BETWEEN CCR5 GENOTYPE AND THE CLINICAL COURSE OF HIV-1 INFECTION

      Annals of internal medicine
    94. KOOT M; VANTWOUT AB; MIEDEMA F; SCHUITEMAKER H
      USE OF IMMUNOLOGICAL AND VIRAL PARAMETERS TO PREDICT PROGRESSION OF HIV-INFECTION DURING NATURAL COURSE AND ANTIRETROVIRAL TREATMENT

      Biodrugs
    95. OLALEYE DO; SHENG ZJ; HOWARD TM; RASHEED S
      ISOLATION AND CHARACTERIZATION OF A NEW SUBTYPE A VARIANT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I FROM NIGERIA

      TM & IH. Tropical medicine & international health
    96. TORRES Y; LEAL M; REY C; MEDRANO FJ; SANCHEZQUIJANO A; LISSEN E
      ACQUISITION OF SYNCYTIUM-INDUCING HIV-1 STRAINS DURING THERAPY WITH ZIDOVUDINE ALONE OR COMBINED WITH ALPHA-INTERFERON OR DIDANOSINE

      European journal of clinical microbiology & infectious diseases
    97. GRUNOW R; VONOVERBECK J; FRUTIG K; FREI E; GERMANN D; FURRER H; PERRIN L; PICHLER WJ
      INHIBITION OF SYNCYTIA-INDUCING (SI) VIRUS BY AUTOLOGOUS SERUM FROM HIV-1-INFECTED INDIVIDUALS

      Clinical and diagnostic virology
    98. BHATTACHARYYA D; BROOKS BR; CALLAHAN L
      POSITIONING OF POSITIVELY CHARGED RESIDUES IN THE V3 LOOP CORRELATES WITH HIV TYPE-1 SYNCYTIUM-INDUCING PHENOTYPE

      AIDS research and human retroviruses
    99. LEITNER T; KOROVINA G; MARQUINA S; SMOLSKAYA T; ALBERT J
      MOLECULAR EPIDEMIOLOGY AND MT-2 CELL TROPISM OF RUSSIAN HIV TYPE-1 VARIANTS

      AIDS research and human retroviruses
    100. DEJONG J; SIMON F; VANDERGROEN G; BAAN E; SARAGOSTI S; BRUNVEZINET F; GOUDSMIT J
      V3 LOOP SEQUENCE-ANALYSIS OF 7 HIV TYPE-1 GROUP-O ISOLATES PHENOTYPEDIN PERIPHERAL-BLOOD MONONUCLEAR-CELLS AND MT-2 CELLS

      AIDS research and human retroviruses


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 07:18:04